Naoko Kanda

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 68

Top Venues

The Journal of dermatology

The Journal of dermatological treatment

Journal of clinical medicine

International journal of molecular sciences

Nippon Medical School Chiba Hokusoh Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Nippon Medical School Chiba Hokusoh Hospital

Japan

Professor :: Dermatology

Publications

Teppei Hagino, Risa Hamada, Mai Yoshida, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan. Clinical drug investigation (2024)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan. The Journal of dermatological treatment 35 (1) (2024)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study. The Journal of dermatological treatment 35 (1) (2024)
Naoko Kanda
Editorial: Special Issue, "Molecular Advances in Skin Diseases 2.0". International journal of molecular sciences 25 (11) (2024)
Teppei Hagino, Risa Hamada, Mai Yoshida, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan. Clinical drug investigation 44 (4) (2024)
Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis. The Journal of dermatological treatment 35 (1) (2024)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study. The Journal of dermatological treatment 35 (1) (2024)
Teppei Hagino, Marina Onda, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Effectiveness of deucravacitinib for genital, nail, and scalp lesions with psoriasis: a 24-week real-world study. Clinical and experimental dermatology (2024)
Naoko Kanda
Editorial: Special Issue, "Molecular Advances in Skin Diseases 2.0". International journal of molecular sciences 25 (11) (2024)
Teppei Hagino, Risa Hamada, Mai Yoshida, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Real-world effectiveness and safety of bimekizumab in Japanese patients with psoriasis: A single-center retrospective study. The Journal of dermatology 51 (5) (2024)
Risa Hamada, Yoko Funasaka, Hidehisa Saeki, Naotaka Serizawa, Teppei Hagino, Yumiko Yano, Hiroshi Mitsui, Naoko Kanda
Author reply to the letter regarding 'Dietary habits in adult Japanese patients with vitiligo'. The Journal of dermatology (2024)
Risa Hamada, Yoko Funasaka, Hidehisa Saeki, Naotaka Serizawa, Teppei Hagino, Yumiko Yano, Hiroshi Mitsui, Naoko Kanda
Dietary habits in adult Japanese patients with vitiligo. The Journal of dermatology (2024)
Teppei Hagino, Risa Hamada, Mai Yoshida, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Risa Hamada, Yoko Funasaka, Hidehisa Saeki, Naotaka Serizawa, Teppei Hagino, Yumiko Yano, Hiroshi Mitsui, Naoko Kanda
Dietary habits in adult Japanese patients with vitiligo. The Journal of dermatology 51 (4) (2024)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Real-world effectiveness and safety of bimekizumab in Japanese patients with psoriasis: A single-center retrospective study. The Journal of dermatology (2024)
Naoko Kanda
Editorial: Special Issue, "Molecular Advances in Skin Diseases 2.0". International journal of molecular sciences 25 (11) (2024)
Risa Hamada, Yoko Funasaka, Hidehisa Saeki, Naotaka Serizawa, Teppei Hagino, Yumiko Yano, Hiroshi Mitsui, Naoko Kanda
Dietary habits in adult Japanese patients with vitiligo. The Journal of dermatology 51 (4) (2024)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study. The Journal of dermatological treatment 35 (1) (2024)
Teppei Hagino, Risa Hamada, Mai Yoshida, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan. Clinical drug investigation 44 (4) (2024)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan. The Journal of dermatological treatment 35 (1) (2024)
Teppei Hagino, Marina Onda, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Effectiveness of bimekizumab for genital, nail, and scalp lesions with psoriasis: A 24-week real-world study. The Journal of dermatology (2024)
Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis. The Journal of dermatological treatment 35 (1) (2024)
Teppei Hagino, Hidehisa Saeki, Naoko Kanda
Biomarkers and Predictive Factors for Treatment Response to Tumor Necrosis Factor-α Inhibitors in Patients with Psoriasis. Journal of clinical medicine 12 (3) (2023)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Efficacy and safety of baricitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan. The Journal of dermatology (2023)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Effects of Biologic Therapy on Laboratory Indicators of Cardiometabolic Diseases in Patients with Psoriasis. Journal of clinical medicine 12 (5) (2023)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
The differential effects of upadacitinib treatment on skin rashes of four anatomical sites in patients with atopic dermatitis. The Journal of dermatological treatment 34 (1) (2023)
Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan. The Journal of dermatological treatment 34 (1) (2023)
Teppei Hagino, Risa Hamada, Mai Yoshida, Eita Fujimoto, Hidehisa Saeki, Naoko Kanda
Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis. Clinical, cosmetic and investigational dermatology 16 (2023)
Teppei Hagino, Mai Yoshida, Risa Hamada, Eita Fujimoto, Hidehisa Saeki, Naoko Kanda
Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate-to-severe atopic dermatitis. The Journal of dermatology (2023)
Teppei Hagino, Hidehisa Saeki, Naoko Kanda
Biomarkers and Predictive Factors for Treatment Response to Tumor Necrosis Factor-α Inhibitors in Patients with Psoriasis. Journal of clinical medicine 12 (3) (2023)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Effects of Biologic Therapy on Laboratory Indicators of Cardiometabolic Diseases in Patients with Psoriasis. Journal of clinical medicine 12 (5) (2023)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Effects of Biologic Therapy on Laboratory Indicators of Cardiometabolic Diseases in Patients with Psoriasis. Journal of clinical medicine 12 (5) (2023)
Kei Hosoya, Taro Komachi, Katsunori Masaki, Isao Suzaki, Hidehisa Saeki, Naoko Kanda, Makoto Nozaki, Yosuke Kamide, Yoshinori Matsuwaki, Yoshiki Kobayashi, Eriko Ogino, Shin-Ichi Osada, Norihiro Usukura, Toshikazu Kurumagawa, Junya Ninomia, Mikiya Asako, Keitaro Nakamoto, Hidenori Yokoi, Manabu Ohyama, Keiji Tanese, Sho Kanzaki, Koichi Fukunaga, Motohiro Ebisawa, Kimihiro Okubo
Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study. Patient preference and adherence 17 (2023)
Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis. The Journal of dermatological treatment 35 (1) (2023)
Mai Yoshida, Yoko Funasaka, Hidehisa Saeki, Masami Yamamoto, Naoko Kanda
Dietary Fiber Inulin Improves Murine Imiquimod-Induced Psoriasis-like Dermatitis. International journal of molecular sciences 24 (18) (2023)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
The Eosinophil-to-Lymphocyte Ratio Acts as an Indicator for Improvement of Clinical Signs and Itch by Upadacitinib Treatment in Atopic Dermatitis. Journal of clinical medicine 12 (6) (2023)
Teppei Hagino, Hidehisa Saeki, Naoko Kanda
Two cases of generalized pustular psoriasis successfully treated with bimekizumab. The Journal of dermatology (2023)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
The Eosinophil-to-Lymphocyte Ratio Acts as an Indicator for Improvement of Clinical Signs and Itch by Upadacitinib Treatment in Atopic Dermatitis. Journal of clinical medicine 12 (6) (2023)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Background factors predicting the occurrence of herpes zoster in atopic dermatitis patients treated with upadacitinib. The Journal of dermatology (2023)
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
The Eosinophil-to-Lymphocyte Ratio Acts as an Indicator for Improvement of Clinical Signs and Itch by Upadacitinib Treatment in Atopic Dermatitis. Journal of clinical medicine 12 (6) (2023)
Teppei Hagino, Hidehisa Saeki, Naoko Kanda
The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan. The Journal of dermatology 49 (11) (2022)
Naoko Kanda
Editorial: Special Issue, "Molecular Advances in Skin Diseases". International journal of molecular sciences 23 (20) (2022)
Saeko Ozaki, Susumu Ichiyama, Michiko Ito, Toshihiko Hoashi, Naoko Kanda, Hidehisa Saeki
Real-world blood examination screening data before initiation of biologics for psoriasis patients. The Journal of dermatology 49 (5) (2022)
Toshihiko Hoashi, Naoko Kanda, Hidehisa Saeki
Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell Carcinoma. International journal of molecular sciences 23 (19) (2022)
Shun Miyazaki, Hajime Nakano, Maki Mizuno, Saeko Ozaki, Toshihiko Hoashi, Naoko Kanda, Hidehisa Saeki
Two novel mutations in the ATP2C1 gene found in Japanese patients with Hailey-Hailey disease. The Journal of dermatology 49 (6) (2022)
Teppei Hagino, Hajime Nakano, Hidehisa Saeki, Naoko Kanda
A Case of Darier's Disease with a Novel Missense Mutation in ATP2A2 Successfully Treated with Calcipotriol/Betamethasone Dipropionate Two-Compound Ointment. Clinical, cosmetic and investigational dermatology 15 (2022)
Naoko Kanda
Psoriasis: Pathogenesis, Comorbidities, and Therapy Updated. International journal of molecular sciences 22 (6) (2021)
Naoko Kanda, Toshihiko Hoashi, Hidehisa Saeki
The Defect in Regulatory T Cells in Psoriasis and Therapeutic Approaches. Journal of clinical medicine 10 (17) (2021)
Susumu Ichiyama, Kazumitsu Sugiura, Toshihiko Hoashi, Naoko Kanda, Hidehisa Saeki
Generalized pustular psoriasis with deficiency of interleukin-36 receptor antagonist associated with sensorineural hearing impairment. The Journal of dermatology 48 (9) (2021)
Teppei Hagino, Shizuka Okazaki, Naotaka Serizawa, Kaori Suzuki, Mio Kaga, Yohei Otsuka, Erina Mikami, Toshihiko Hoashi, Hidehisa Saeki, Hiroki Matsuda, Hiroshi Mitsui, Naoko Kanda
Dietary Habits in Japanese Patients with Alopecia Areata. Clinical, cosmetic and investigational dermatology 14 (2021)
Michiko Ito, Koichi Akutsu, Mitsuaki Isobe, Shizuka Okazaki, Susumu Ichiyama, Toshihiko Hoashi, Naoko Kanda, Hidehisa Saeki
Generalized pustular psoriasis complicated with idiopathic retroperitoneal fibrosis successfully treated with infliximab. The Journal of dermatology 48 (9) (2021)
Atsuko Fukuyasu, Masahiro Kamata, Carren Sy Hau, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Yayoi Tada, Naoko Kanda
Serum interleukin-10 level increases in patients with severe signs or symptoms of herpes zoster and predicts the duration of neuralgia. The Journal of dermatology 48 (4) (2021)
Michiko Ito, Susumu Ichiyama, Toshihiko Hoashi, Naoko Kanda, Ai Iwashita, Chiaki Kawamoto, Hidehisa Saeki
Severe Psoriasis Successfully Treated with Brodalumab after Eradication of Hepatitis C Virus with Glecaprevir and Pibrentasvir: A Case Report. Annals of dermatology 33 (6) (2021)
Naotaka Serizawa, Shizuka Okazaki, Yohei Otsuka, Mototaka Koto, Kyochika Okabe, Michiko Ito, Takashi Morita, Toshihiko Hoashi, Hidehisa Saeki, Namiko Abe, Miho Mori, Yukari Okubo, Yumiko Yano, Hiroshi Mitsui, Naoko Kanda
Dietary habits in Japanese patients with palmoplantar pustulosis. The Journal of dermatology 48 (3) (2021)
Maki Mizuno, Go Horiguchi, Satoshi Teramukai, Susumu Ichiyama, Michiko Ito, Toshihiko Hoashi, Naoko Kanda, Hidehisa Saeki
Association study of transition of laboratory marker levels and transition of disease activity of atopic dermatitis patients treated with dupilumab. The Australasian journal of dermatology 62 (4) (2021)
Susumu Ichiyama, Michiko Ito, Toshihiko Hoashi, Naoko Kanda, Toyoki Natsuno, Hidehisa Saeki
Severe atopic dermatitis effectively treated with dupilumab changed from interleukin-5 inhibitors for concomitant severe bronchial asthma. The Journal of dermatology 48 (2) (2020)
Teppei Hagino, Mototaka Koto, Shin-Ichi Ansai, Toshihiko Hoashi, Hidehisa Saeki, Naoko Kanda
Case of subcorneal pustular dermatosis during carfilzomib treatment for immunoglobulin G κ multiple myeloma. The Journal of dermatology 48 (1) (2020)
Naoko Kanda, Toshihiko Hoashi, Hidehisa Saeki
Nutrition and Psoriasis. International journal of molecular sciences 21 (15) (2020)
Yoko Matano, Takashi Morita, Michiko Ito, Shizuka Okazaki, Mototaka Koto, Yuri Ichikawa, Ryoko Takayama, Toshihiko Hoashi, Hidehisa Saeki, Naoko Kanda
Dietary habits in Japanese patients with chronic spontaneous urticaria. The Australasian journal of dermatology 61 (3) (2020)
Naoko Kanda, Nanami Nakadaira, Yohei Otsuka, Norito Ishii, Toshihiko Hoashi, Hidehisa Saeki
Linear IgA bullous dermatosis associated with ulcerative colitis: A case report and literature review. The Australasian journal of dermatology 61 (1) (2019)
Michiko Ito, Takashi Morita, Shizuka Okazaki, Mototaka Koto, Yuri Ichikawa, Ryoko Takayama, Toshihiko Hoashi, Hidehisa Saeki, Naoko Kanda
Dietary habits in adult Japanese patients with atopic dermatitis. The Journal of dermatology 46 (6) (2019)
Susumu Ichiyama, Tomomi Komatsu, Toshihiko Hoashi, Naoko Kanda, Kojiro Nagai, Yuta Yamada, Shin-Ichi Ansai, Hidehisa Saeki
Treatment with apremilast was beneficial for chronic graft-versus-host disease skin lesion in a patient with psoriasis. The Journal of dermatology 46 (6) (2019)
Naoko Kanda, Mototaka Koto, Toshihiko Hoashi, Hidehisa Saeki
Case of alopecia areata during dupilumab treatment for atopic dermatitis. The Journal of dermatology 46 (9) (2019)
Hiroko Yamashita, Takashi Morita, Michiko Ito, Shizuka Okazaki, Mototaka Koto, Yuri Ichikawa, Ryoko Takayama, Toshihiko Hoashi, Hidehisa Saeki, Naoko Kanda
Dietary habits in Japanese patients with psoriasis and psoriatic arthritis: Low intake of meat in psoriasis and high intake of vitamin A in psoriatic arthritis. The Journal of dermatology 46 (9) (2019)
Naoko Kanda, Toshihiko Hoashi, Hidehisa Saeki
The Roles of Sex Hormones in the Course of Atopic Dermatitis. International journal of molecular sciences 20 (19) (2019)
Yuri Ichikawa, Hajime Nakano, Shin-Ichi Ansai, Toshihiko Hoashi, Hidehisa Saeki, Naoko Kanda
Case of Hailey-Hailey disease with a novel missense/in-frame deletion mutation in ATP2C1 successfully treated with cyclosporine. The Journal of dermatology 46 (12) (2019)
Susumu Ichiyama, Toshihiko Hoashi, Naoko Kanda, Hiroshi Hashimoto, Masakazu Matsushita, Kazuhisa Nozawa, Takashi Ueno, Hidehisa Saeki
Psoriasis vulgaris associated with systemic lupus erythematosus successfully treated with apremilast. The Journal of dermatology 46 (6) (2018)

Naoko Kanda.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Naoko Kanda